Life Sciences

A new study confirms that COVID-19 patients who lose their sense of smell face sustained psychological and physical harm, even months or years later. The finding has implications for workplace productivity, healthcare costs, and how employers should support workers recovering from long COVID.EN

Researchers created human brain immune cells from stem cells to model how inflammation spreads after traumatic brain injury. The advance could accelerate drug development for TBI treatments and reduce reliance on animal testing—a significant opportunity for biotech firms developing neurotrauma therapies.EN

A Swedish nationwide study shows that obesity-related cardiovascular risk stems from both genetic predisposition and environmental factors—a finding that could reshape how insurers, employers, and public health agencies assess and address cardiac risk. The dual nature of the risk suggests prevention strategies must target both populations at genetic risk and broader lifestyle interventions.EN

Researchers have identified shared genetic pathways between stress-related psychiatric disorders and autoimmune diseases, suggesting the two conditions may stem from common biological roots. The finding could reshape how clinicians diagnose and treat patients with overlapping conditions, and may open new avenues for pharmaceutical intervention in both disease categories.EN

A chromosomal variation affecting roughly 1 in 1,000 people shows measurable impacts on brain development in children, according to new research from Swedish twins tracked into adulthood. The findings could help clinicians identify at-risk children earlier and inform genetic counseling for families, while opening new markets for diagnostic testing and targeted interventions.EN

Researchers in Southeast China have developed a risk assessment tool that blends genetic markers with lifestyle factors to predict breast cancer susceptibility. The approach could help insurers, healthcare systems, and pharmaceutical companies better stratify patients and personalize prevention strategies in an underserved population.EN

Researchers tested whether over-the-counter ibuprofen interferes with muscle building during resistance training and found it has minimal impact on the biological mechanisms that drive hypertrophy. The finding matters for fitness enthusiasts and supplement makers: it suggests casual painkiller use won't sabotage workout gains, though questions remain about higher doses or chronic use.EN

Researchers found that tiny RNA molecules circulating in blood correlate with dangerous cholesterol deposits in coronary arteries, suggesting a potential early warning system for heart disease. If validated, the finding could enable doctors to identify high-risk patients before they experience cardiac events—reshaping how cardiologists screen and treat millions of people globally.EN

A large Swedish study finds that psoriasis severity—measured by standard clinical scales—independently predicts cardiovascular events, even after accounting for other risk factors. The finding could reshape how dermatologists and cardiologists assess patient risk and may justify earlier intervention in patients with extensive skin disease.EN

Researchers have demonstrated that synthetic DNA and protein molecules can prevent the repetitive genetic mutations that cause Friedreich's ataxia, a devastating inherited neurological disorder. The finding, published in Nucleic Acids Research, opens a potential treatment pathway for a rare disease with no cure—and validates a molecular strategy that could apply to other repeat-expansion disorders affecting thousands of patients.EN

Researchers have mapped how glial cells—the brain's support infrastructure—vary dramatically across regions, ages, and between sexes. The findings could reshape how neurodegenerative diseases are understood and treated, with implications for pharmaceutical development and personalized medicine approaches in neurology.EN

Researchers discovered that calcium buildup during early muscle fatigue paradoxically accelerates force development, even as overall strength declines. The finding could reshape understanding of muscle performance in aging and disease, with implications for athletic training protocols and therapies targeting neuromuscular disorders.EN

Researchers using advanced DNA sequencing identified genetic causes in a significant portion of patients with ataxia and neuromuscular disorders—conditions that previously went undiagnosed. The findings could reshape clinical testing protocols and accelerate drug development for rare neurological diseases affecting hundreds of thousands globally.EN

Scientists have identified a critical problem undermining a promising new cancer treatment: engineered immune cells designed to kill multiple myeloma tumors are instead destroying each other. A new study reveals how to prevent this self-sabotage by modifying the cells' surface properties, potentially unlocking a therapy that has shown early promise but faced significant hurdles in clinical development.EN

A new study reveals that adult women with Turner syndrome show a distinctive cognitive profile marked by significant gaps between verbal and non-verbal abilities, alongside elevated rates of ADHD and autism. The findings could reshape how clinicians screen for and support neurodevelopmental conditions in this population, with implications for educational planning and workplace accommodations.EN

Scientists have developed a technique to observe how drug receptors move and shift when medications bind to them—in real time, inside living cells. The advance could accelerate drug discovery by letting companies test thousands of compounds faster and identify which ones work best at the molecular level.EN

A longitudinal study of 64 patients found that those with obsessive-compulsive disorder consume significantly less fiber than healthy controls, yet their gut bacteria composition remained largely unchanged before and after therapy. The finding suggests OCD's link to microbiome health may be weaker than suspected, potentially redirecting research funding and treatment development priorities in mental health.EN

Researchers found that the combination of weightlessness and radiation exposure triggers harmful immune cell buildup in muscle, a concern for long-duration space missions. The finding could inform medical countermeasures needed for crewed Mars missions and deep-space exploration programs now in development.EN

Researchers have identified a sudden mobilization of immune cells in the placenta during labor, revealing how the body prepares for childbirth at the cellular level. The finding could inform new approaches to managing labor complications and understanding immune responses during pregnancy—a critical period affecting maternal and fetal health outcomes.EN

Researchers have developed a blood-based test that detects cancer DNA to monitor B-cell lymphoma patients during treatment. The approach could reduce reliance on invasive imaging and biopsies, potentially lowering costs and allowing doctors to catch treatment failures faster.EN

Researchers have identified a previously unknown mechanism by which immune cells trigger inflammation in the airways in response to bacterial infection. The finding, involving a protein called TLR4 and a signaling molecule called IL-26, could lead to new approaches for treating severe respiratory infections or reducing excessive inflammation—a significant concern for companies developing immunotherapy drugs.EN

A single strain of Bacteroides caccae — a harmless gut bacterium — is transmitted from mothers to children far more frequently than other related bacteria, according to a large Scandinavian study. The finding could help researchers understand how early-life microbiome development shapes health outcomes and informs strategies for probiotic development and disease prevention.EN

A new study finds that melanoma patients who take metformin for diabetes show improved survival rates compared to those who don't use the drug. The finding could reshape treatment strategies for the roughly 20% of melanoma patients with diabetes, potentially offering a low-cost intervention that extends life.EN

Researchers have pinpointed a specific enzyme—pyruvate dehydrogenase kinase—that fuels the vascular inflammation underlying atherosclerosis and heart attacks. The discovery opens a path for drug developers to intervene earlier in cardiovascular disease, potentially shifting how companies approach prevention therapies and diagnostic strategies.EN

Researchers found that a specific form of a common protein helps stabilize dangerous arterial plaques and reduces heart attack risk. The discovery could lead to new treatments targeting heart disease, the leading cause of death globally, and may reshape how doctors assess which patients face the greatest cardiovascular danger.EN